Cibc Bancorp Usa Inc. Intellia Therapeutics, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 14,670 shares of NTLA stock, worth $149,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,670Holding current value
$149,340% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
338Shares Held
101MCall Options Held
1.66MPut Options Held
1.05M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$121 Million1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$112 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$97.7 Million0.0% of portfolio
-
Contrarius Group Holdings LTD Hamilton, D05.89MShares$60 Million4.6% of portfolio
-
Morgan Stanley New York, NY4.12MShares$41.9 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $774M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...